Biotechnology Industry Organization's (BIO) 2005 Annual International Convention will be held at the Pennsylvania Convention Center in Philadelphia on June 19-22, 2005. This year's conference is hosted by the tri-state region of Pennsylvania, New Jersey, and Delaware. More than 18,000 biotech executives, investors, journalists, policy makers and scientists from more than 60 countries are expected to attend.
The convention will feature greater overseas representation with two international plenary sessions, country seminars with 16 countries presenting the latest developments in national biotechnology policies, and a ministerial seminar with federal level ministers from at least four countries. BIO will host a record number of high ranking international dignitaries leading national delegations from more than 60 countries.
For more details, contact: email@example.com
IBC Life Sciences will organize Bio-Collaborations Asia at the Boston Park Plaza Hotel, Boston, MA, on May 18-20, 2005. The conference will explore the issues relating to building and growing a pharmaceutical or biotechnology business in Asia. It will feature select case experiences of US and European companies who have ventured into Asia, either through joint venture, licensing or outsourcing collaborations. Conference speakers will examine the challenges, the tribulations and the successes of these partnerships.
The conference will include focused sessions on IP and Regulatory concerns in China and India, value propositions for licensing, outsourcing and offshoring to Asia, best practices and case studies of successful collaborations between East and West. IBC in association with The Federation of Indian Chambers of Commerce and Industry (FICCI) will also organize a half-day "India Pharma Forum 2005" on May 18, 2005.
For more details, contact: firstname.lastname@example.org
BIO VentureForum East 2005
The Biotechnology Industry Organization (BIO), in partnership with 12 state biotechnology associations and BIOTECanada will organize BIO VentureForum East 2005 at the Intercontinental Hotel-Buckhead, Atlanta, Georgia on May 9-11, 2005. The conference will bring venture capitalists together with promising seed, early- and late-stage private biotechnology product and platform companies from the East Coast. It will showcase 120 individual company presentations to leading North American venture capital firms in the life sciences field. Workshops and plenary sessions will be offered on trends in the biotech industry, with special focus on key success factors for early stage companies, R&D, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.
To ensure high quality deal flow, an advisory board made up of 30 equity capital leaders, will review and evaluate the corporate profiles of companies through an application process. Selected entrepreneurs will also attend regional BIO Venture Forum Boot Camps.
For more details, contact: email@example.com or firstname.lastname@example.org
PABORD 2005, a pharmaceutical and biotech outsourcing, research and development exhibition and conference, will be held in London on September 14-15, 2005. The event will focus exclusively on the theme of outsourcing in the research and development of new medicines. Companies both large and small are adopting this increasingly popular business strategy. The conference is relevant to service providers and R&D organizations active across the entire discovery and development chain from lead generation to product registration.
For more details, contact: email@example.com
Drug Discovery & Development Asia-Pacific
IBC will organize Drug Discovery & Development Asia-Pacific conference on June 1-3, 2005 in Singapore. The conference will take an in-depth look at the innovative progress being made by various Asia-Pacific countries. Conference speakers will present case studies of successful East-West collaboration and lessons learned in the Asian market, as well as deliver scientific updates on disease-specific drug discovery and research. Be it information on innovative scientific updates or search for outsourcing opportunities such as finding new molecules to in-license or forming research partnerships, this conference will have it all.
For more details, contact: firstname.lastname@example.org
Drug Delivery World meet
Drug Delivery World, a three-day conference which will be organized by IBC Life Sciences on May 16, 2005 in CA, USA, will serve as a targeted educational platform for leaders in the drug delivery field to assess technology, foster strategic relationships, find more effective ways to extend product lifecycles, and optimize the pipeline through compound-enabling programs. The meet will include three panel discussions and two in-depth tracks on business and technology to help pharmaceutical professionals build new relationships and address the growing number of delivery options available within the industry. Panel discussions will focus on building true alliances, advanced transdermal products, and fast dissolve ODT technologies.
For more details, contact: email@example.com
RELATENZ 2005, an international conference on enzyme technology will be held on September 20- 23, 2005 at the University of Matanzas, Cuba. The meet will emphasize on current developments on basic and applied enzymology enzyme structure and function, biocatalysis, enzyme immobilization and stabilization. The meet will feature plenary lectures, session lectures, oral communications and poster sessions on enzymes in biotechnological, industrial, agricultural and environmental applications.
For further details, contact: firstname.lastname@example.org
Phacilitate Vaccine Forum Spring 2005
Phacilitate's fourth annual Spring Vaccine Forum will be held on May 23-25, 2005 in Amsterdam, Netherlands. The conference will provide an opportunity for leaders from across the vaccines sector to meet, and to discuss solutions to their common strategic, regulatory and technological challenges. The three-day conference will feature plenary presentations, workshops, breakout sessions and panel discussions.
For more information, contact: email@example.com
The IIR will organize a three-day conference on Immunogenicity for Protein-based Therapeutics on May 23, 2005 in San Franciso, CA, USA. This 6th annual conference will provide new data on assay development and validation, screening and neutralizing assays, coupled with a concentration on the latest process techniques and technological advancements through all new, original case studies. As the conference has developed and grown, IIR has recognized the challenges faced by scientists working in immunogenicity and provided the first forum to exclusively address immunogenicity issues. For the first four years, it focused primarily on the antibody immunogenicity for biologics and vaccines. Beginning in 2004, and continuing through this year, it has expanded the agenda to include the latest cell based bioassay validation, screening and neutralizing assays, and improvement in processes and techniques.
For more details, contact Anne Moyer, e-mail: firstname.lastname@example.org